Blueprint Medicines Corp
BPMCDelisted Jul 18, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597264
Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2025 vs. Q3 2025
How the institutions holding Blueprint Medicines Corp changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 12 | 8 | −4 |
| Shares | 37.9K | 26.9K | −11.0K (−29.1%) |
| Value | $2.58M | $2.57M | −$2.49K (−0.1%) |
New holders (3)
Institutions that held Blueprint Medicines Corp at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wall Street Access Asset Management, LLC | 300 | $0 | 0.00% |
| Flagship Wealth Advisors, LLC | 443 | $0 | 0.00% |
| Keating Financial Advisory Services, Inc. | 4 | $0 | 0.00% |
Sold out (7)
Institutions that held Blueprint Medicines Corp at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Van Eck Associates Corp | 132 | $17.0K |
| IFP Advisors, Inc | 66 | $8.54K |
| Advisor Group Holdings, Inc. | 23 | $2.95K |
| Bessemer Group Inc | 209 | $0 |
| Los Angeles Capital Management LLC | 11,138 | $0 |
| ORG Partners LLC | 11 | $0 |
| Crowley Wealth Management, Inc. | 200 | $0 |